Grass and olive allergy vaccine trial for teens to older adults
Part of Ear, nose & throat, Immune system & allergy, Lungs & breathing clinical trials.
This Phase 3 trial tests whether an allergy treatment can reduce symptoms caused by grass and olive pollen. It also checks safety, especially for breathing and allergic reactions, in people with confirmed grass/olive allergy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You (or your child’s) doctor has confirmed informed consent, and you can follow trial instructions
- You are between 12 and 65 years old
- Your allergy is confirmed by skin testing and blood tests showing sensitivity to grass and/or olive pollen
- You have an allergy history like runny nose/sneezing (rhinitis) and/or eye symptoms, sometimes with controlled mild to moderate asthma
- You need a smartphone to track symptoms and medicines during the study
- If you are able to become pregnant, you must use reliable birth control and have a negative pregnancy test; the study excludes pregnancy and breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This phase 3 trial tests a specific allergy treatment (an “immunotherapy” shot) for people whose symptoms are triggered by grass and cypress tree pollen. It aims to see if the treatment is safer and more effective at reducing allergy symptoms over time, especially for nose/eye symptoms and some people with asthma.
This Phase 3 study tests whether dust-mite allergy treatment (likely allergy shots) can reduce allergy symptoms and improve safety. It focuses on people whose nose/eye allergy is triggered by house dust mites and who may also have controlled asthma.
This trial tests an under-the-tongue tablet for people with dust mite allergies causing moderate to severe nasal symptoms or mild-to-moderate asthma. The goal is to see if it improves symptoms and can replace or reduce the need for allergy medicines.
This trial studies how well standardized oak (Quercus ilex and Quercus robur) allergen extracts match your specific allergy. It may help refine allergy testing and treatment planning for people with oak-triggered rhinitis, eye symptoms, and/or asthma.
This study tests if adding vitamin D to a new type of allergy shot (ILIT) works better than standard allergy drops for grass pollen allergy. It may help if you have moderate to severe seasonal allergy symptoms.
This trial tests an experimental antibody (IL4Rα monoclonal antibody) for people with seasonal allergic rhinitis (hay fever) that is not well controlled by standard treatments like nasal steroid sprays. The goal is to see if this new treatment can help reduce allergy symptoms during pollen season.
Hear when a new Rhinoconjunctivitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.